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Morbidity andmortality associated with viral infections
increase with age, although the underlying mecha-
nismsareunclear.Here,we investigatedwhether aging
alters inflammatory responses during systemic viral
infection and thereby contributes to virus-induced
death. We found that infection of aged mice with
systemicherpesviruses led to rapid increases in serum
IL-17, neutrophil activation, and mortality due to hepa-
tocyte necrosis. In contrast, all young mice survived
infection, displaying weaker IL-17 induction and neu-
trophil activation. Natural killer T (NKT) cells isolated
from the livers of aged mice produced more IL-17
than did young cells, and adoptively transferred aged
NKT cells induced liver injury in young mice impaired
in viral control. Importantly, IL-17 neutralization or
neutrophil depletion during viral infection reduced liver
damage and prevented death of aged mice. These
results demonstrate that, during systemic viral infec-
tion, aging alters thehost-pathogen interaction toover-
produce IL-17, contributing to liver injury and death.
INTRODUCTION
The elderly are at increased risk formicrobial infection andmalig-
nancy (Linton andDorshkind, 2004), indicating that aging impairs
immunity. These individuals are less able to overcome viral infec-
tions and subsequently exhibit high morbidity and mortality after
infection (Gorina et al., 2008), imposing a heavy burden on health
care resources (Han et al., 1999; Kaplan and Angus, 2003;
Kaplan et al., 2002). Several studies have demonstrated that
aging adversely affects various components of immunity (Linton
and Dorshkind, 2004; Miller, 1996). However, most studies have
focused on adaptive T cell responses (Garcia and Miller, 2001;
Haynes et al., 1999; Linton et al., 1996; Linton and Dorshkind,
2004; Thoman and Weigle, 1982), leaving it unclear as to how
aging modifies other host defenses against infection.
Studies in humans and mice have shown that aging is associ-
atedwith aberrant cytokine production and inflammation (Bru¨u¨ns-
gard and Pedersen, 2003; Rosenstiel et al., 2008). Aging is associ-
ated with elevated levels of several proinflammatory cytokines,446 Cell Host & Microbe 6, 446–456, November 19, 2009 ª2009 Elseincluding IL-1, IL-6, and TNF-a. The elevation in IL-6 has been of
particular interest, as this cytokine has recently been shown to
be important for the differentiation of Th17 CD4+ T cells (Korn
et al., 2007; Weaver et al., 2007). However, whether age-related
aberrancies in inflammatory responses result from impaired
host-pathogen interactionsandwhether theseaberrant responses
affect theoutcomeofsystemicviral infections inolder individuals is
unclear. In this study, we compared inflammatory responses to
systemic infection with either herpes simplex type 2 virus (HSV-
2) or murine cytomegalovirus (MCMV) between young and aged
mice. Our findings reveal that aberrant IL-17A responses to
systemic viral infection contribute to the death of aged hosts via
aneutrophil-dependentprocess.Thesefindings suggest that ther-
apies aimed at inactivating IL-17Amay avert immune pathology in
older individuals with systemic viral infections.
RESULTS
Systemic Viral Infection Induces Proinflammatory
Cytokine Overproduction and Death in Aged Mice
To begin to understand how aging modifies the inflammatory
response to systemic viral infection, we infected young (2–4
months), middle-aged (8–10 months), and aged (18–20 months)
C57BL/6 mice with HSV-2, a human viral pathogen that activates
plasmacytoid dendritic cells (pDCs) (Lund et al., 2003). We found
that all young and middle-aged mice survived infection, whereas
all agedmicesuccumbedto it (Figure1A).Mortalitywasassociated
withasignificantelevation insystemic levelsof IL-17A, IL-6 (Figures
1B and 1C), and TNF-a (Figure S1). The elevation in IL-17A levels
and mortality in response to HSV-2 infection was not limited to
one genetic background of mice, as similar responses were found
in the BALB/c strain (Figure S2). We also found that infection of
aged BALB/c mice with the alternate pathogen, MCMV, induced
death as well as an elevation in IL-17A, IL-6, and TNF-a levels
(Figure S3). On the other hand, young BALB/cmice survived infec-
tion and exhibited lower levels of these cytokines (FigureS3). Thus,
in aged mice, systemic viral infection induces an aberrantly high
IL-17A response, which is associated with mortality.
Systemic HSV-2 Infection Elevates Serum IL-17A Levels
in Aged Mice in a Dose-Dependent Fashion
Next, the age-dependent augmentation of IL-17A responses
to systemic viral infection was further characterized using dose-
response experiments. We first detected differences in serumvier Inc.
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Aging, Viral Infection, and IL-17Figure 1. Aged Mice Succumb to Systemic Active HSV-2 Infection and Exhibit Elevated Serum Inflammatory Cytokine Levels
(A) Survival of aged (18–20 months), middle-aged (8–10 months), and young (2–4 months) C57BL/6 mice following HSV-2 infection. All aged mice died within
5 days of infection, whereas the other groups all survived up to 50 days after infection, at which time the experiment was terminated. p < 0.001, aged group versus
the other groups (Log rank test).
(B and C) Serum levels of IL-17A (B) and IL-6 (C) following HSV-2 infection. Values represent the mean ±SD of three independent experiments, each performed in
triplicate. p < 0.01, aged group versus the other groups (ANOVA).
(D and E) Survival (D) and IL-17A responses (E) in agedmice infectedwith active or heat-inactivatedHSV-2. The difference in survival between the active and heat-
inactivated groups was significant (p < 0.001, Log rank).
(F and G) Effect of acyclovir or PBS on survival (p = 0.005, Log rank) (F) and IL-17A responses (G) in agedmice infected with HSV-2. Values in (E) and (G) represent
the mean ±SD of two independent experiments, each performed in triplicate.IL-17A levels between aged mice and their younger counterparts
at a 1 3 105 pfu dose of HSV-2 (Figure S4A). The difference in
systemic IL-17A levels between young and agedmice grew larger
with increasingdosesofHSV-2 (FigureS4A). Incontrast to thisage-
dependent elevation in the systemic IL-17A response, systemic
IFNa responses to viral infection were lower in aged mice than in
youngmice (Figure S4B). Moreover, measurement of viral plaques
revealed that these age-related changes in IL-17A and IFNa
responses were accompanied by a reduced ability to clear HSV-
2 (Figure S4C). Finally, mortality was noted in aged mice infected
with 1 3 107 pfu of HSV-2, but not in those infected with a 1 3
105 pfu (Figure S5). A comparison of agedmice infectedwith these
twodoses revealed that thehigher infectingdose inducedagreater
increase in systemic IL-6, IL-17A, and TNF-a levels (Figure S5).
Infection with Active Virus Promotes Higher IL-17A
Levels and Mortality Than Infection
with Heat-Inactivated Virus
Todeterminewhethersystemic infectionwithactiveviruspromotes
deathof agedmice,we infectedagedmicewitheitheractiveHSV-2Cell Hostor heat-inactivated HSV-2. We found that, in aged mice, infection
with 107 pfu of the active formof the virus was lethal and increased
systemic IL-17A levels, whereas infection with the same dose of
inactive formwas not lethal and increased IL-17A to a lesser extent
(Figures1Dand1E).Moreover, administrationof theantiviral agent,
acyclovir, to agedmice just before HSV-2 infection and 24 hr after
infection reduced IL-17A production and prevented mortality (Fig-
ures 1F and 1G). Taken together, these results imply that the active
formof theHSV-2 issuperior to the inactive form inelevating IL-17A
and inducing mortality in aged mice.
Aging Augments Neutrophil-Attracting Chemokine
Production, Neutrophil Activity, and Liver Neutrophil
Accumulation Following HSV-2 Infection
The finding that aging increases the IL-17A response prompted
us to measure the production of macrophage inflammatory
protein-1a (MIP-1a), a neutrophil- and macrophage-homing
chemokine that is induced by IL-17A (Aggarwal and Gurney,
2002). We found that, following HSV-2 infection, serum levels
of MIP-1a and myeloperoxidase (MPO, a marker of neutrophil& Microbe 6, 446–456, November 19, 2009 ª2009 Elsevier Inc. 447
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2A and 2B). MPO levels were also present at higher concentra-
tions in the livers of aged infected mice than in those from young
infected mice (Figure 2C). Accordingly, livers from aged infected
mice contained a greater number of GR1+CD11b+ F4/80 cells
than livers from young infected mice (Figure 2D).
HSV-2 Infection Induces Hepatocyte Necrosis
in Aged Mice, but Not in Young Mice
Neutrophils can induce acute hepatocyte injury and necrosis
(Ramaiah and Jaeschke, 2007), which are accompanied by
release of alanine aminotransferase (ALT). We found that, during
the first 72 hr after HSV-2 infection, aged mice had higher serum
ALT levels than young mice (Figure 2E). Similar findings were
noted in BALB/c mice infected with MCMV (Figure S6). Further-
more, a comparison of serum ALT levels in aged mice infected
with either 105 or 107 pfu of HSV-2 demonstrated that the higher
infecting dose was superior in inducing ALT release than the
lower dose (Figure S7). Importantly, this age-related increase
in serum ALT levels was partially prevented when mice were in-
fected with heat-inactivated HSV-2 or given acyclovir just prior
to viral infection (Figure 2F). Liver damage in aged mice was
Figure 2. Aged Mice Exhibit Greater MIP-1a Production, Neutrophil Activity, Liver Neutrophil Accumulation, and Hepatocyte Necrosis Than
Young Mice after HSV-2 Infection
(A) Effect of HSV-2 infection on serum MIP-1a levels in aged and young mice. p < 0.01, aged infected versus young infected (ANOVA).
(B) Serum neutrophil activity (MPO levels) in aged and young HSV-2-infected mice. p = 0.007, aged infected versus young infected (ANOVA).
(C) Liver MPO levels in aged and young mice 12 hr after HSV-2 infection. p = 0.05, aged infected versus young infected (t test).
(D) Accumulation of liver GR1+CD11b+ F4/80 cells in aged and young HSV-2-infected mice at 12 hr after infection. p < 0.01, aged infected versus young infected
(t test), n = 4/group.
(E) Serum ALT levels (measure of liver necrosis) in aged and young HSV-2-infected mice. p < 0.01, aged infected versus young infected (ANOVA).
(F) Serum ALT levels in aged HSV-2-infected mice treated with acyclovir or in aged mice infected with heat-inactivated HSV-2. Values in (A), (B), and (E) represent
themean ±SD of three independent experiments, each performed in triplicate. Values in (C), (D), and (F) represent themean ±SD of two independent experiments,
each performed in triplicate.
(G) Histological imagesof livers fromyoung andagedmice thatwere left uninfected (young [a] andaged [c]) or infected for 24 hr (young [b] andaged [d]). Noninfected
aged liverswere similar to young infectedandnoninfected livers, except for normal age-relatedchangessuchasperivascular collectionsof lymphocytesandplasma
cells (c, arrow). Livers from infectedagedmiceexhibitedmarkedmultifocal hepatocellular necrosis (d, arrow),withmultifocal-to-diffusehepatocellular fatty changes.
Numerous polymorphonuclear cells were present in necrotic areas (arrowhead, e [inset of d]). Scale bars: a–d = 500 mm; e = 200 mm. n = 3–6 mice per group.448 Cell Host & Microbe 6, 446–456, November 19, 2009 ª2009 Elsevier Inc.
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Aging, Viral Infection, and IL-17Figure 3. Aging Augments HSV-2-Induced Production of IL-17A by NKT Cells
(A and B) IL-17A serum levels in young (A) andmiddle-aged (9months of age) (B)WT andNKT cell-deficient (CD1d/) mice infectedwith HSV-2. p = 0.03,middle-
aged WT versus middle-aged CD1d/ (ANOVA).
(C) Intracellular IL-17A labeling in NKT cells (glycolipid-loaded CD1d tetramer+ TCRb+ cells) gated within liver lymphocytes from aged and young mice receiving
PBS or HSV-2. A representative experiment is shown from six independent experiments.
(D) HSV-2-induced IL-17A production in cultured liver NKT lymphocytes isolated from aged and youngmice. *p < 0.01, young infected versus aged infected cells
(t test). Values represent the mean ±SD of three independent experiments, each performed in triplicate.
(E)RORgT gene expression in liver NKT cells at rest and after HSV-2 infection. *p = 0.01, young infected versus aged infected cells (t test). Values in (A), (B), and (E)
represent the mean ±SD of two independent experiments, each performed in triplicate. In all cases, n = 3 mice/group/experiment.confirmed by histological analysis. As shown in Figure 2G, liver
tissue from aged HSV-2-infected mice showed clear evidence
of hepatocyte necrosis, while livers from young HSV-2-infected
mice showed no histopathological changes. Histological exam-
ination of other organs and tissues from infected animals did not
reveal any signs of age-specific necrosis (data not shown).
Aging Augments IL-17A Production by NKT
Cells after HSV-2 Infection
The rapid kinetics of IL-17A induction in aged HSV-2-infected
mice indicate that IL-17A release primarily arises from the innate
immune response. Recent studies have demonstrated that NKT
cells produce IL-17A in response to synthetic NKT cell ligands
(Michel et al., 2007; Rachitskaya et al., 2008). Furthermore, aging
induces an accumulation of NKT cells (Faunce et al., 2005),
which can mediate age-dependent liver injury (Inui et al., 2002;
Kawabata et al., 2008). Hence, we infected 2- to 4-month-old
WT and NKT cell-deficient (CD1d/) mice with HSV-2 andCell Hostmeasured the serum IL-17A response. Six hours after infection,
systemic IL-17A levels were lower in CD1d/ mice than in WT
mice (Figure 3A). We repeated this experiment with middle-
aged mice (i.e., 9 months of age) and found that the difference
in serum IL-17A levels between WT and CD1d/ mice was
even larger (Figure 3B). Similar results were noted in an alternate
form of mutant mice that were deficient in NKT cells (Ja18/)
(Figure S8).
Next, we analyzed IL-17A responses in liver NKT cells (PBS-
57-loaded CD1d tetramer+, TCRb+) from young and aged mice
at 12 hr after HSV-2 infection. The proportion of liver NKT cells
that expressed IL-17A was greater in aged mice than in young
mice (Figure 3C). Consistent with prior work (Inui et al., 2002),
noninfected aged mice also manifested higher numbers of liver
NKT cells than their younger counterparts, though these
numbers did not increase after infection (Figure S9). To deter-
mine whether aging augments IL-17A responses on a per cell
basis, we isolated liver NKT cells from noninfected aged and& Microbe 6, 446–456, November 19, 2009 ª2009 Elsevier Inc. 449
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Aging, Viral Infection, and IL-17Figure 4. Impaired Viral Control and Aged NKT Cells Synergize to Induce Liver Injury during HSV-2 Infection
(A) Serum ALT and IL-17A levels were measured in young HSV-2-infected mice that were subjected to pDC depletion, adoptive transfer of NKT cells, or a combi-
nation of these procedures. pDC depletion with a-PDCA-1 antibody (a-PDCA-1 antibody group versus isotype control group, p = 0.01 for ALT and p < 0.05 for
IL-17A [ANOVA]) is shown in (A).
(B) Adoptive transfer of aged NKT (ANKT) cells (ANKT versus PBS, p < 0.001 for ALT and p < 0.05 for IL-17A [ANOVA]).
(C) Combination of pDC depletion and adoptive transfer of NKT cells. Animals received ANKT cells or young NKT (YNKT) cells. ALT and IL-17A levels in mice
undergoing a combination of pDC depletion and adoptive transfer of ANKT cells significantly differed from those in all other groups (p < 0.001, ANOVA). Values
in (A)–(C) represent themean ±SD of two independent experiments, each performed in triplicate. n = 4mice per group/experiment. Young uninfectedmice under-
going pDC depletion or adoptive transfer with NKT cells did not exhibit elevations in IL-17A and ALT (data not shown).young mice. We then activated these cells ex vivo with HSV-2.
We found that, during in vitro HSV-2 activation, aged NKT cells
produced higher levels of IL-17A than young NKT cells (Fig-
ure 3D). Moreover, mRNA levels of RORgT, an IL-17-promoting
transcription factor (Ivanov et al., 2006; Michel et al., 2007;
Rachitskaya et al., 2008), were greater in aged NKT cells than
in young NKT cells, both at rest and after HSV-2 infection (Fig-
ure 3E). Finally, NKT cells have been shown to produce IL-17A
in an IL-6-independent manner, and experiments with middle-
aged WT and IL-6-deficient mice revealed that HSV-2-induced
production of IL-17A was IL-6 independent (Figure S10).
Impaired Viral Control and Aged NKT Cells Synergize
to Induce Liver Injury during Viral Infection
Our results indicate that, in aged animals, liver injury and
mortality during viral infection are associated with two factors:
impaired containment of the virus (Figure S4C) and the presence
of a cell with superior IL-17A-producing capabilities (i.e., NKT
cell) (Figure 3C). Therefore, we investigated whether the pres-
ence of these two factors synergized to induce liver injury during450 Cell Host & Microbe 6, 446–456, November 19, 2009 ª2009 Elviral infection in young mice. To impair viral control in young
mice, we depleted these hosts of pDCs, which are critical to
host defense to HSV-2 (Lund et al., 2006; Stout-Delgado et al.,
2008). In young hosts, pDC depletion before viral infection using
aPDCA-1 antibody led to a greater viral load in the liver than
treatment with isotype control (Figure S11), confirming the crit-
ical role of pDCs in host defense to HSV-2.
Next, we measured serum ALT and IL-17A levels in young
mice that underwent either pDC depletion or adoptive transfer
of aged NKT cells. Our results revealed that ALT and IL-17A
levels were greater in mice undergoing pDC depletion than in
control animals (mice receiving isotype control antibody) (Fig-
ure 4A). ALT and IL-17A levels were also greater in young in-
fected hosts undergoing adoptive transfer of aged NKT cells
than in those not receiving these cells (Figure 4B). However,
elevating serum IL-17A levels in the absence of infection through
administration of recombinant IL-17A did not induce ALT release
or mortality, regardless of host age (Figure S12). In young in-
fected hosts, a combination of pDC depletion and adoptive
transfer of aged NKT cells increased ALT levels to a greatersevier Inc.
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Aging, Viral Infection, and IL-17Figure 5. IL-17A Neutralization Blocks HSV-2-Induced Death, MIP-1a Production, and Neutrophil Activity in Aged Mice
(A–D) Effect of anti-IL-17A antibody on survival of aged mice (A) (p = 0.007, anti-IL-17A antibody versus isotype control, Log rank test), serum IL-17A and IL-6
levels (B) (n = 6 mice per group; *p < 0.01, anti-IL-17A antibody versus isotype control, t test), serum MIP-1a levels and MPO activity (C) (p < 0.01, anti-IL-17A
antibody versus isotype control, ANOVA), and liver MPO production and GR1+CD11b+ F4/80 accumulation at 12 hr after infection (D) (p < 0.01, anti-IL-17A anti-
body versus isotype control, ANOVA). Values in (B)–(D) represent the mean ±SD of two independent experiments, each performed in triplicate.extent than a comparable degree of pDC depletion combined
with adoptive transfer of young NKT cells (Figure 4C). The
pDC-depleted young mice that were adoptively transferred
with aged, but not young, NKT cells exhibited signs of illness
during viral infection (e.g., reduced movement, grooming, and
feeding); however, they eventually survived infection. Finally,
we found that young infected hosts that underwent pDC deple-
tion and received aged NKT cells exhibited higher ALT levels and
IL-17A levels than young HSV-2-infected mice undergoing only
pDC depletion or adoptive transfer of aged NKT cells (Figure 4C).
Importantly, the effect of these combined manipulations on ALT
and IL-17A production was greater than the sum of the effects
resulting from either manipulation alone (Figure 4C). These
data indicate that impaired viral control and the presence of
aged NKT cells synergize to induce liver injury during HSV-2
infection.
IL-17A Inhibition Prevents Lethality of HSV-2
in Aged Mice
To understand the role of IL-17A in HSV-2-induced death of aged
mice, we tested the effect of an IL-17A-neutralizing antibody on
survival. Treatment of aged mice with the IL-17A-neutralizingCell Hostantibody at the time of HSV-2 infection did not affect viral clear-
ance from either the spleen or liver during the time course of
study (Figure S13A). Similar findings were noted when serum
viral load was measured by PCR (Figure S13B). Nevertheless,
this treatment led to 100% survival in this group (6/6) (Figure 5A).
On the other hand, administration of an isotype control antibody
to aged mice led to the survival of only a single mouse (1/6 or
17%) (Figure 5A). A comparison of cytokine production between
HSV-2-infected mice receiving IL-17A-neutralizing antibody and
receiving isotype control antibody revealed that IL-17A neutrali-
zation not only prevented death, but also significantly reduced
serum IL-17A, IL-6, and TNF-a levels at 24 hr after infection
(Figures 5B and S14). These changes were accompanied by
a reduction in MIP-1a and MPO serum levels (Figure 5C). Liver
MPO levels and neutrophil accumulation were also lower in the
IL-17A neutralization group than in the isotype control group
(Figure 5D). Importantly, these protective effects of IL-17A
neutralization were associated with a reduction in ALT levels
and hepatocyte necrosis (Figures 6A and 6B). In addition, the
ability of anti-IL-17A treatment to prevent mortality was noted
in aged BALB/c mice infected with MCMV (Figures S15A and
S15B). IL-17A neutralization was also capable of preventing& Microbe 6, 446–456, November 19, 2009 ª2009 Elsevier Inc. 451
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S15C and S15D). These data indicate that HSV-2-induced death
in aged mice is IL-17A dependent.
Neutrophil Depletion Prevents HSV-2-Induced
Death in Aged Mice
The above results suggest that neutrophils are the cellular medi-
ators of HSV-2-induced liver damage and death in agedmice. To
further investigate this possibility, we depleted aged mice of
neutrophils with a specific neutrophil-depleting mAb (Daley
et al., 2008) and then infected these animals with HSV-2. All
neutrophil-depleted mice (8/8) survived HSV-2 infection, while
none of the isotype control mice survived (0/8) (Figure 7A). In
addition, ALT levels were lower in neutrophil-depleted mice
Figure 6. IL-17A Neutralization Inhibits
HSV-2-Induced Hepatocyte Necrosis in
Aged Mice
(A) Effect of anti-IL-17A antibody on HSV-2-
induced increases in systemic ALT levels. Values
represent the mean ±SD of two independent
experiments, each performed in triplicate.
(B) Effect of anti-IL-17A antibody on HSV-2-
induced histopathological changes in the aged
liver at 48 hr after infection (n = 3 mice per group).
Isotype antibody treatment (a–d) was associated
with random multifocal necrosis (a, b *), scattered
polymorphonuclear cells (arrows, d [inset of b]),
and marked multifocal-to-diffuse fatty changes
(steatosis) in some hepatic lobes (c; arrowheads
[inset of a]). Treatment with anti-IL-17A prior to
infection (e, f [inset of e]) prevented the induction
of histopathological changes. Scale bars: a, b,
and e = 500 mm; c, d, and f = 200 mm.
than in isotype control animals (Fig-
ure 7B). Similar results were noted in
aged BALB/c mice infected with MCMV
(Figures 7C and 7D). These data indicate
that neutrophils are the cellular mediators
of herpes virus-induced death in aged
mice.
DISCUSSION
Aging is known to augment inflammatory
responses, but whether these alterations
contribute to death following viral infec-
tion is unknown. In the current study, we
found that, following either HSV-2 or
MCMV infection, aged mice produced
higher serum levels of several inflamma-
tory cytokines, in particular IL-17A.
Importantly, neutralizing IL-17A in aged
mice during HSV-2 or MCMV infection
reduced liver injury and increased
survival (Figures 5 and 6). These findings
are consistent with prior work showing
that IL-17 signaling induces liver injury in
nonaging models (Nagata et al., 2008).
IL-17A neutralization also reduced serum levels of other inflam-
matory cytokines, including IL-6 and TNF-a, indicating that
elevated IL-17A levels control the production of other cytokines
in this experimental system. This is consistent with prior work
demonstrating that IL-17A can induce the production of IL-6
by a variety of cells (Fossiez et al., 1996). Our findings demon-
strate that aging induces an aberrant overproduction of IL-17A
during systemic viral infection and that this IL-17A overproduc-
tion can lead to death secondary to liver damage.
In the aged mice studied here, neutrophil-mediated liver
necrosis was responsible for HSV-2-induced death. Prior work
in nonaging models has demonstrated that neutrophils are key
mediators of liver cell injury (Ramaiah and Jaeschke, 2007). We
found that 24 hr after infection, aged virally infected mice, but452 Cell Host & Microbe 6, 446–456, November 19, 2009 ª2009 Elsevier Inc.
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Aging, Viral Infection, and IL-17Figure 7. Depletion of 1A8+ Cells Prevents HSV-2 or MCMV-Induced Death in Aged Mice
(A and B) Effect of depletion of 1A8+ cells on survival (A) (p < 0.001, Log rank test) and serum ALT levels (B) (1A8+ versus isotype, p < 0.001, ANOVA) in aged
C57BL/6 mice infected with HSV-2. Noninfected mice did not exhibit an increase in serum ALT (data not shown).
(C and D) Effect of depletion of 1A8+ cells on survival (C) (p < 0.001, Log rank test) and serum ALT levels (D) (1A8+ versus isotype, p < 0.001, ANOVA) in aged
BALB/c mice infected with MCMV. Noninfected mice did not exhibit an increase in serum ALT (data not shown). Values in (B) and (D) represent the mean ±SD
of two independent experiments, each performed in triplicate.not their young infected counterparts, exhibited severe hepato-
cyte necrosis that was associated with neutrophil activation
(Figure 2). Moreover, both liver injury and mortality were blocked
by neutrophil depletion (Figure 7). Both outcomes were driven
by IL-17A, as seen by the ability of IL-17A neutralization to
reduce levels of MIP-1a (a neutrophil-attracting chemokine)
and decrease neutrophil enzyme activity (Figure 5). These data
indicate that neutrophils are a key cellular mediator of IL-17A-
dependent death in aged mice with systemic viral infections.
Our study provides evidence that NKT cells are important for
the rapid production of IL-17A during HSV-2 infection, because
NKT-deficient mice exhibited a much weaker IL-17A response
than WT mice (Figure 3). These results indicate that NKT cells
are a major source of IL-17A in our experimental systems but
do not exclude the possibility that other cell types with known
IL-17-producing capabilities, such as gd T cells and CD4+
T cells (O’Brien et al., 2009; Stockinger and Veldhoen, 2007),
contribute to the age-induced IL-17 response in our study. While
recent studies have demonstrated that NKT cells produce
IL-17A when activated by a-galactosylceramide or LPS instilla-
tion (Michel et al., 2007; Rachitskaya et al., 2008), here we
demonstrate and characterize the ability of NKT cells to produce
IL-17A during a viral infection. Our work suggests that IL-17-
producing NKT cells may have pathological consequences
during viral infection. Prior work indicates that NKT cells are
important for host defenses against infection with HSV and other
viruses (Grubor-Bauk et al., 2003, 2008). Furthermore, studies
with MCMV have indicated that NKT cells are activated via the
presence of an accessory cell to maximally induce IFNg produc-
tion during infection (Tyznik et al., 2008; Wesley et al., 2008). Our
results indicate that NKT cells can respond directly to in vitroCell Hoststimulation by HSV-2 to produce IL-17A, although our study
does not exclude the possibility that an accessory cell is involved
in vivo. In the future, it will be important to identify the viral
components (e.g., viral glycolipids) that stimulate NKT cells to
produce IL-17A.
We found that aging increased expression of RORgT, a tran-
scription factor that may control IL-17A production by NKT cells
(Michel et al., 2007; Rachitskaya et al., 2008).Why aging led to an
upregulation of the RORgT gene in NKT cells is unclear. One
possible avenue for future investigation is exploration of the
role of oxidative stress, as many studies have shown that age-
induced phenotypes correlate with increasing levels of oxidative
stress (reviewed in Bokov et al., 2004).
Our work provides evidence that two factors (i.e., impaired
viral control and agedNKT cells) cooperate in inducing liver injury
during viral infection in our experimental models. A recent study
demonstrated that aging impairs pDC function and, in this way,
disrupts the IFNa response, inhibiting HSV-2 or MCMV clear-
ance in agedmice (Stout-Delgado et al., 2008). In young infected
mice, impeding viral clearance via pDC depletion and adoptively
transferring aged, but not young, NKT cells induced greater ALT
release than eithermanipulation alone and imparted a phenotype
similar to that seen in agedmice (Figure 4). Although these young
mice became ill, they eventually survived viral infection, suggest-
ing that young hosts contain unidentified protective factors or
that aged hosts contain unidentified disease-promoting factors
that contribute to mortality during viral infection. A recent study
found that IL-17A inhibits NK function, reducing clearance of
vaccinia virus (Kawakami et al., 2009). This study may explain
the synergy between impaired viral control and elevated IL-17A
levels in our model, as it is possible that the augmented IL-17A& Microbe 6, 446–456, November 19, 2009 ª2009 Elsevier Inc. 453
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further exacerbating liver injury. Nevertheless, our results indi-
cate that, in aged hosts, viral infection induces liver injury through
at least two factors: impaired containment of the virus and aged
NKT cells, which exhibit an exaggerated IL-17A response.
In future studies, it will be important to determine whether local
or organ-specific infection in aged hosts induces a phenotype
similar to that described here in response to systemic viral infec-
tions. This may depend on whether NKT cells accumulate with
age at local sites of infection. In addition, clinical studies should
be conducted to determine whether older people exhibit
increased levels of IL-17 during viral infection. A recent study
showed that Th17 cells enhance viral persistence in a murine
chronic viral infection model (Hou et al., 2009). If Th17 cells are
found to be elevated in aged humans with viral infections, then
perhaps age-dependent increases in IL-17 responses may not
only contribute to immune pathology during systemic viral infec-
tions but also promote chronic viral infections. In any case, our
data clearly show that aging alters the host-virus interaction by
inducing liver damage and mortality through a pathway involving
IL-17A. Thus, anti-IL-17A therapies may hold promise for pre-
venting immune pathology and increasing survival in older indi-
viduals with systemic viral infections.
EXPERIMENTAL PROCEDURES
Mice
Aged (18–20 months), middle-aged (8–10 months), and young (2–4 months)
C57BL/6 or BALB/c mice were purchased from the NIA rodent facility.
C57BL/6 IL-6/mice were purchased from Jackson Laboratory (Bar Harbor,
ME). C57BL/6 CD1d/ mice and BALB/c Ja18/ were generously provided
by Dr. Erol Fikrig and Dr. McMahon-Pratt, respectively (both of Yale University;
NewHaven, CT), andwere aged in our colony. The institutional animal care and
use committee at Yale University approved the use of animals in this study.
Animals with any evidence of skin lesions, weight loss, or lymphadenopathy
were excluded from the study.
In Vivo Infection
HSV-2 virus was generously provided by Dr. Akiko Iwasaki (Yale University)
and grown in Vero cells as previously described (Lund et al., 2003).
Gradient-purified virus was administered via tail vein injection at a dose of
1 3 107 pfu or at other doses as indicated. HSV-2 viremia was measured via
a plaque assay as previously described (Gadjeva et al., 2004). Briefly, diluted
serum or supernatants obtained from homogenized spleen and liver samples
were plated on a confluent layer of Vero cells, seeded at 1 3 106 cells/well in
10% FCS DMEM. The cells were incubated overnight at 37C, and then
plaques were counted by visual inspection following a Giemsa stain. Results
are expressed as units/ml of serum or units/liver. Viral load was also assessed
by real-time PCR (see below). HSV-2 was heat inactivated at 56C for 1 hr. The
MCMV Smith strain was generously provided by Anthony Van Den Pol (Yale
University). Mice received 1 3 103 pfu of MCMV via intravenous injection, as
described elsewhere (Delale et al., 2005).
In Vivo Reagents
IL-17A-neutralizing antibody (rat anti-mouse mAb, clone M210, IgG2a) was
generously provided by Amgen (Seattle, WA) (Chu et al., 2007). It was admin-
istered i.p. at a dose of 150 mg/mouse at 24 hr prior to viral infection or at other
times indicated. Anti-1A8 mAb and isotype control were obtained from Bio-
Xcell (Lebanon, NH). Both were used at a concentration of 0.5 mg/mouse
and administered i.p. 72 hr prior to infection. Acyclovir (Sigma-Aldrich; St.
Louis) or PBS (control) was administered i.p. at a dose of 0.6mg/mouse. These
agents were administered at the time of HSV-2 infection and 24 hr after infec-
tion. For pDC depletion, mice received 0.5 mg of anti-PDCA-1 monoclonal
antibody (Miltenyi Biotec; Bergisch Gladbach, Germany) or isotype control454 Cell Host & Microbe 6, 446–456, November 19, 2009 ª2009 Els(BioXcell) i.p. 24 hr before infection, as previously reported (Stout-Delgado
et al., 2008). Recombinant IL-17A (eBioscience; San Diego, CA) was adminis-
tered i.p. at a dose of 250 pg/gm body weight.
Histology
A routine selection of tissues from all organ systems was subjected to histo-
pathologic examination. The tissues were processed, embedded in paraffin,
sliced into 5 mm thick sections, and stained with hematoxylin and eosin using
routine methods. Samples were evaluated by investigators blinded to the
experimental group. Digital light microscopic images were acquired using
a Zeiss Axioskop microscope, an AxioCam MRC Camera, and AxioVision
4.4 imaging software (Carl Zeiss MicroImaging, Inc.; Thornwood, NY). The
resulting images were optimized using Adobe Photoshop 8.0 (San Jose, CA).
Cell Sorting, Flow Cytometry, and NKT Cell Culture
Liver lymphocytes were isolated as previously described (Crispe, 2003). These
cells were stained with fluorescently labeled PBS-57 glycolipid-loaded or un-
loaded CD1d tetramers (NIAID Tetramer Facility; Atlanta) and FITC-tagged rat
anti-mouse TCRb+ mAb (eBioscience). The cells were subjected to intracel-
lular cytokine stainingwith PE-tagged rat anti-mouse IL-17mAb (eBioscience),
and NKT cells were identified by gating on the PBS-57-loaded CD1d tetramer+
TCRb+ population, as previously described (Liu et al., 2006). Liver NKT cells
(i.e., PBS-57-loaded CD1d tetramer+ TCRb+) were also sorted by FACs for
further in vitro studies. For cytokine staining, NKT cells were harvested 12 hr
after HSV-2 infection and then cultured in the presence of cell permeability
agents andGolgi stop (eBioscience). For in vitro studies, 13 105 FACs-purified
NKT cells were plated in RPMI supplemented with 10% FBS (200 ml) and
treated with 50 pfu heat-inactivated HSV-2 for 18 hr at 37C. Cells were then
processed for real-time PCR and cell supernatants for ELISA.
Adoptive Transfer of NKT Cells
Liver NKT cells were purified as described above, and 13 105 cells were adop-
tively transferred via intravenous tail vein injection at 72 hr prior to infection.
RNA and DNA Purification
RNA was extracted using the QIAGEN RNeasy Mini Kit (QIAGEN; Valencia, CA)
and quantified by A260/280 absorbance readings. SuperScript III Reverse Tran-
scriptase (Invitrogen) was used, according to the manufacturer’s instructions, to
create complementary DNA frommRNA.DNAwas extracted from 10 ml of serum
samples using the QIAGEN DNeasy Blood and Tissue Kit; eluted into 50 ml of
sterile, double-distilled water; and quantified by A260/280 absorbance readings.
Real-Time PCR
Real-time PCR for RORgT was performed using TaqMan gene expression
probe/primer sets (Applied Biosystems; Foster City, CA). Reaction mixtures
had a final volume of 25 ml and contained complementary DNA from 20 ng
of reverse-transcribed total RNA, TaqMan Gene expression primer/probe
mix, and TaqMan Gene Expression Master Mix. Real-time PCR for HSV-2
DNAwas performed using SYBRGreen Universal PCRMasterMix (Applied Bi-
osystems). The subsequent real-time PCR was performed in a final volume of
25 ml containing 20 ng of DNA, 150 nM forward and reverse primers (Wada
et al., 2009), and SYBR Green Universal PCR Master Mix. Known concentra-
tions of HSV-2 DNA were included in all PCR reactions to assess sensitivity.
PCRwas performed in 96-well plates using theMJ Research detection system
(MJ Research, Inc.; Waltham, MA). All reactions were performed in triplicate.
An amplification curve analysis was performed, and dilution curve standards
were generated to identify primer sets and conditions yielding specific prod-
ucts with 100% amplification efficiency. Relative mRNA levels were calculated
using the comparative cycle threshold method (User Bulletin #2, Applied Bio-
systems). GAPDH and cyclophilin mRNA levels served as invariant controls.
ELISA
Culture supernatants or sera were analyzed for IL-6, IL-17A, IFNa, TNF-a, and
MIP-1a using ELISA kits from BD Biosciences (San Diego, CA), R&D Systems
(Minneapolis), orPBL (Piscataway,NJ) according to themanufacturers’ instruc-
tions.Neutrophil activitywasdeterminedbymeasuringMPO levels,whichwere
also analyzed using a commercially available ELISA kit (Hycult Biotechnology;
Uden, The Netherlands) according to the manufacturer’s protocol.evier Inc.
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Serum ALT levels were measured using the Infinity ALT Assay Kit (Fisher
Scientific; Suwance, GA) according to the supplied instructions.
Statistical Analysis
Survival analysis was performed using the Log rank method. Comparison of
means was performed using a two-tailed t test or repeated-measures
ANOVA. All data were analyzed using GraphPad prism software (San Diego,
CA). Values of p less than 0.05 were considered significant.
SUPPLEMENTAL DATA
Supplemental Data include 15 figures and can be found online at http://www.
cell.com/cell-host-microbe/supplemental/S1931-3128(09)00347-3.
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